Tugwell PS - Search Results

1

Observations from the OMERACT Drug Safety Summit, May 2008.

Simon LS, Strand CV, Boers M, Brooks PM, Henry D, Tugwell PS. Simon LS, et al. Among authors: tugwell ps. J Rheumatol. 2009 Sep;36(9):2110-3. doi: 10.3899/jrheum.090590. J Rheumatol. 2009. PMID: 19738222

2

Standardized assessment of adverse events in rheumatology clinical trials: summary of the OMERACT 7 drug safety module update.

Lassere MN, Johnson KR, Boers M, Carlton K, Day RO, de Wit M, Edwards IR, Fries JF, Furst DE, Kirwan JR, Tugwell PS, Woodworth TG, Brooks PM. Lassere MN, et al. Among authors: tugwell ps. J Rheumatol. 2005 Oct;32(10):2037-41. J Rheumatol. 2005. PMID: 16206366

3

How to ascertain drug safety in the context of benefit. Controversies and concerns.

Simon LS, Strand CV, Boers M, Brooks PM, Tugwell PS, Bombardier C, Fries JF, Henry D, Goldkind L, Guyatt G, Laupacis A, Lynd L, Macdonald T, Mamdani M, Moore A, Saag KG, Silman AJ, Stevens R, Tyndall A. Simon LS, et al. Among authors: tugwell ps. J Rheumatol. 2009 Sep;36(9):2114-21. doi: 10.3899/jrheum.090591. J Rheumatol. 2009. PMID: 19738223

4

The OMERACT filter for Outcome Measures in Rheumatology.

Boers M, Brooks P, Strand CV, Tugwell P. Boers M, et al. J Rheumatol. 1998 Feb;25(2):198-9. J Rheumatol. 1998. PMID: 9489805 No abstract available.

5

Patient based methods for assessing adverse events in clinical trials in rheumatology. Progress report for the OMERACT Drug Toxicity Working Party. Outcome Measures in Rheumatology.

Gazarian M, Tugwell P, Boers M, Bombardier C, Brooks P, Day R, Strand V, Wells G. Gazarian M, et al. J Rheumatol. 1999 Jan;26(1):207-9. J Rheumatol. 1999. PMID: 9918265

6

Minimal clinically important differences: review of methods.

Wells G, Beaton D, Shea B, Boers M, Simon L, Strand V, Brooks P, Tugwell P. Wells G, et al. J Rheumatol. 2001 Feb;28(2):406-12. J Rheumatol. 2001. PMID: 11246688 Review.

7

OMERACT 9 - 9th International Consensus Conference on outcome measures in rheumatology clinical trials.

Tugwell P, Boers M, Strand V, Simon LS, Brooks P, Tugwell P, Boers M, Brooks P, Simon L, Strand V. Tugwell P, et al. J Rheumatol. 2009 Aug;36(8):1765-8. doi: 10.3899/jrheum.090261. J Rheumatol. 2009. PMID: 19671811 No abstract available.

8

Minimal disease activity for rheumatoid arthritis: a preliminary definition.

Wells GA, Boers M, Shea B, Brooks PM, Simon LS, Strand CV, Aletaha D, Anderson JJ, Bombardier C, Dougados M, Emery P, Felson DT, Fransen J, Furst DE, Hazes JM, Johnson KR, Kirwan JR, Landewé RB, Lassere MN, Michaud K, Suarez-Almazor M, Silman AJ, Smolen JS, Van der Heijde DM, van Riel PL, Wolfe F, Tugwell PS. Wells GA, et al. Among authors: tugwell ps. J Rheumatol. 2005 Oct;32(10):2016-24. J Rheumatol. 2005. PMID: 16206362

9

Investigating the validity of the minimal disease activity state for patients with rheumatoid arthritis treated with abatacept.

Wells GA, Boers M, Li T, Tugwell PS. Wells GA, et al. Among authors: tugwell ps. J Rheumatol. 2009 Feb;36(2):260-5. doi: 10.3899/jrheum.080059. Epub 2009 Jan 22. J Rheumatol. 2009. PMID: 19208559

10

Measuring worker productivity: frameworks and measures.

Beaton D, Bombardier C, Escorpizo R, Zhang W, Lacaille D, Boonen A, Osborne RH, Anis AH, Strand CV, Tugwell PS. Beaton D, et al. Among authors: tugwell ps. J Rheumatol. 2009 Sep;36(9):2100-9. doi: 10.3899/jrheum.090366. J Rheumatol. 2009. PMID: 19738221 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

347 results

Search Page

Filters